Health ❯ Healthcare ❯ Pharmacology

Diabetes

SGLT-2 Inhibitors Type II Diabetes Type 2 Diabetes Medications Type 2 Diabetes Cardiovascular Diseases

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

A Nature Medicine analysis of nearly one million U.S. insurance records reports measurable cardiovascular risk reductions in routine care.

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes